| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.079 | 0.08 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |